Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
1,208 results
1208
Total Filings
$7039.3B
Total Raised
101
424B4 Offerings
318
ATM Programs
257
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 | INSW | Energy | Oil & Gas Midstream | $5.5B | Public Offering |
$91.62
floor
|
$110.24 | +20.3% | — | — | B. Riley | International Seaways, Inc. is selling up to $200 million of common shares at-the-market through four sales agents; proceeds will be used for general corporate purposes. |
| May 11 | MAC | Real Estate | REIT - Retail | $6.8B | Public Offering |
$19.99
floor
|
$22.89 | +14.5% | — | — | Goldman Sachs, J.P. Morgan, Deutsche Bank | Macy's (MAC) is issuing 16 million common shares via Goldman Sachs; pricing and proceeds use not specified in this preliminary prospectus supplement dated May 11, 2026. |
| May 8 | NKTR | Healthcare | Biotechnology | $1.7B | Public Offering |
$85.09
floor
|
$59.24 | -30.4% | — | — | — | Nektar Therapeutics selling up to $150 million in common stock at-the-market through Guggenheim Securities and H.C. Wainwright; proceeds for general corporate purposes. |
| May 8 | O | Real Estate | REIT - Retail | $51.4B | ATM | — | $55.14 | — | — | — | Barclays, BofA, Citigroup, Deutsche Bank, Goldman Sachs, Jefferies | Realty Income Corporation (O) is selling up to 150 million common shares at market prices through multiple agents under a sales agreement dated May 7, 2026, with proceeds for general corporate purposes. |
| May 8 | VRDN | Healthcare | Biotechnology | $2.3B | Secondary | — | $20.00 | — | 7.4M | — | Jefferies | Viridian Therapeutics (VRDN) is offering 7,352,942 shares of common stock at $17.00 per share to raise approximately $125 million, with net proceeds of $117.5 million before expenses. |
| May 8 | LTRX | Technology | Communication Equipment | $322M | ATM | — | $7.22 | — | — | — | Needham | Lantronix is selling up to $30 million in common stock at-the-market through Needham & Company and Canaccord Genuity, with proceeds for general corporate purposes. |
| May 8 | UBXG | Technology | Software - Infrastructure | $4M | Public Offering |
$0.30
floor
|
$5.03 | +1576.7% | — | — | — | U-BX Technology Ltd. is offering 15,166,668 units (each containing one Class A Ordinary Share and one warrant) on a best-efforts basis; filing does not specify offering price or use of proceeds. |
| May 8 | PHVS | Healthcare | Biotechnology | $2.2B | Public Offering | — | $31.73 | — | — | — | — | Pharvaris N.V. is offering 3,874,664 ordinary shares at $29.68 per share, raising approximately $115 million in gross proceeds for general corporate purposes. |
| May 8 | SVCO | Technology | Software - Application | $277M | ATM |
$12.46
floor
|
$8.45 | -32.2% | 753K | $9M | Jefferies | Silvaco Group, Inc. is raising up to $35 million through an at-the-market offering of common stock via Jefferies LLC, with proceeds for general corporate purposes. |
| May 8 | ED | Utilities | Regulated Electric | $38.1B | Public Offering |
$106.39
floor
|
$103.33 | -2.9% | — | — | Barclays, BofA, Jefferies, J.P. Morgan, KeyBanc, Wells Fargo | Consolidated Edison is raising up to $2 billion through an equity distribution agreement with ten sales agents to sell common shares at market prices over time for general corporate purposes. |
| May 8 | SDSTW | — | — | — | ATM | — | — | — | 10.4M | — | B. Riley | Stardust Power Inc. is selling up to $5 million of common stock at market prices through B. Riley Securities; proceeds will be used for general corporate purposes. |
| May 8 | HOVRW | — | — | — | Public Offering |
$2.81
floor
|
— | — | — | — | — | New Horizon Aircraft Ltd. is selling 9,254,889 Class A ordinary shares at $2.81 per share in a registered direct offering, raising approximately $26.0 million, with proceeds for general corporate purposes. |
| May 8 | ARTV | Healthcare | Biotechnology | $344M | Public Offering | — | $7.03 | — | 23.9M | — | Jefferies, Cowen, Needham | ARTV sells 23.9M common shares and 2.2M pre-funded warrants at $11.52/share, raising ~$300M gross proceeds for general corporate purposes. |
| May 8 | OUST | Technology | Hardware, Equipment & Parts | $2.9B | ATM | — | $40.00 | — | — | — | Oppenheimer | Ouster, Inc. is selling up to $100 million in common stock at-the-market through four agents, with proceeds for general corporate purposes and no specified use mentioned. |
| May 8 | DGXX | Technology | Software - Infrastructure | $419M | ATM |
$6.19
floor
|
$4.25 | -31.3% | — | — | — | Digi Power X Inc. is selling up to $175 million in subordinate voting shares at-the-market through A.G.P./Alliance Global Partners at a 3.0% commission, with proceeds for general corporate purposes. |
| May 8 | ODTX | — | — | $1.1B | Secondary |
$18.00
floor
|
$22.44 | +24.7% | — | — | J.P. Morgan, Cowen, Oppenheimer | Odyssey Therapeutics raises $279 million selling 15.5 million shares at $18/share in IPO; net proceeds of $259.5 million for general corporate purposes. |
| May 7 | ALEC | Healthcare | Biotechnology | $208M | ATM |
$2.57
floor
|
$1.87 | -27.2% | — | — | Cowen | Alec Technologies (ALEC) is offering up to $125 million in common stock through TD Securities at-the-market, with proceeds for general corporate purposes; stock priced at $2.57 per share as of May 6, 2026. |
| May 7 | CYTK | Healthcare | Biotechnology | $8.2B | Public Offering |
$66.05
floor
|
$65.64 | -0.6% | — | — | Jefferies, Needham | Cytek Biosciences is selling 9,859,155 common shares at $71.00 per share to raise approximately $700 million in gross proceeds, with underwriters having a 30-day option for 1,478,873 additional shares. |
| May 7 | VTMX | Real Estate | Real Estate - Development | $2.7B | Public Offering |
$35.69
floor
|
$32.39 | -9.2% | — | — | Barclays, J.P. Morgan, Morgan Stanley, BofA | Corporación Inmobiliaria Vesta (VTMX) is offering 70,047,634 common shares globally, with pricing to be determined; proceeds will fund operations. |
| May 7 | GPCR | Healthcare | Biotechnology | $1.9B | ATM |
$40.84
floor
|
$32.69 | -20.0% | — | — | Cantor Fitzgerald | GPCR established a $400 million at-the-market offering of ADSs through Leerink Partners and Cantor Fitzgerald, with $58.5 million already sold; remaining $341.5 million will fund general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →